How HIF-1α Affects IgA Production and Intestinal Inflammation
Author Information
Author(s): Meng Xianyi, Asadi-Asadabad Sahar, Cao Shan, Song Rui, Lin Zhen, Safhi Mohammed, Qin Yi, Tcheumi Tactoum Estelle, Taudte Verena, Ekici Arif, Mielenz Dirk, Wirtz Stefan, Schett Georg, Bozec Aline
Primary Institution: Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen
Hypothesis
HIF-1α plays a critical role in IgA-producing B-cell differentiation and intestinal inflammation.
Conclusion
HIF-1α is essential for IgA production, and its stabilization can alleviate intestinal inflammation.
Supporting Evidence
- B cells lacking HIF-1α showed lower IgA production.
- Promoting HIF-1α stabilization improved IgA class switching.
- HIF-1α deficiency led to exacerbated intestinal inflammation in DSS-induced colitis.
- Acetyl-CoA supplementation improved IgA production in Hif1a-deficient B cells.
- Roxadustat treatment enhanced IgA production and reduced colitis symptoms.
Takeaway
HIF-1α helps B cells make a special type of antibody called IgA, which is important for gut health. When HIF-1α is not working well, it can lead to more inflammation in the intestines.
Methodology
The study involved using mice with HIF-1α deficiency in B cells and assessing IgA production and intestinal inflammation through various assays.
Limitations
The study primarily focused on mouse models, which may not fully replicate human conditions.
Participant Demographics
Mice used in the study were C57BL/6 WT and Hif1a cKO mice.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website